Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-018175

General Counsel and Secretary sold 1,913 shares at $79.67 ($152,409)

  • General Counsel and Secretary acquired 3,825 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2024-02-18 Option exercise +3,825 59,284 D
KASINGER JAMES R. General Counsel and Secretary 2024-02-20 Sale −1,913 $79.67 $152,409 57,371 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2024-02-18 Option exercise · Restricted Stock Units −3,825 7,650 D
Open-market sales · 1,913 sh · avg $79.67 · $152,409
Loading xslF345X05/ownership.xml…